Why the study?
Does pretreatment hepatitis C virus RNA titer predict serum ALT response to interferon-beta therapy in patients with chronic hepatitis C?
Does pretreatment hepatitis C virus RNA titer predict serum ALT response to interferon-beta therapy in patients with chronic hepatitis C?
Pretreatment serum level of hepatitis C virus RNA is a more important predictor of ALT response to interferon therapy than virus genotype in patients with chronic hepatitis C.
Answers are grounded in this paper and cite their sources.
Lower HCV RNA titer was associated with interferon response; hypothesis-generating for titer as predictor but should not yet guide therapy in chronic hepatitis C.
We quantified serum hepatitis C virus RNA titers and determined hepatitis C virus subtypes in chronic hepatitis C patients treated with interferon-beta to investigate relationships among serum ALT response, serum hepatitis C virus titer and hepatitis C virus subtype. Of 146 chronic hepatitis C patients who received interferon-beta therapy, 24 patients with sustained serum ALT normalization (complete responders) and 26 patients without serum ALT normalization (nonresponders) were randomly selected. Detection, typing and quantitation of hepatitis C virus were performed by means of the "single-tube" polymerase chain reaction method. Of the 24 complete responders, 21 (87.5%) became negative for hepatitis C virus RNA, whereas 21 (80.8%) of the 26 nonresponders remained positive. Hepatitis C virus infections with types I, II, III, IV, II + III and III + IV occurred in 0 (0%), 22 (51.2%), 10 (23.3%), 1 (2.3%), 7 (16.5%) and 3 (7.9%) patients, respectively. The mean pretreatment hepatitis C virus RNA titer of complete responders (0.4 +/- 2.0 x 10(4) CID50/ml) was significantly lower than that of nonresponders (3.8 +/- 4.5 x 10(4) CID50/ml) (p < 0.01). Regardless of HCV subtype, patients with more than 10(4) CID50/ml of HCV did not show serum ALT normalization, whereas complete serum ALT response was seen in most cases with less than 10(2) CID50/ml HCV. These results show that mixed infections with different hepatitis C virus subtypes appear to be more common than previously reported and that the pretreatment serum level of hepatitis C virus RNA is a more important predictor of outcome of interferon therapy than is virus genotype.
No takes yet. Share an insight, caveat, or question.
Kobayashi et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: